Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Language
Publication year range
1.
Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
Veldman, Mark W; Reading, Carl C; Farrell, Michael A; Mullan, Brian P; Wermers, Robert A; Grant, Clive S; Thompson, Geoff B.
AJR Am J Roentgenol ; 191(6): 1740-4, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19020245

ABSTRACT

OBJECTIVE: The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. CONCLUSION: Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.


Subject(s)
Ethanol/administration & dosage , Hyperparathyroidism/therapy , Multiple Endocrine Neoplasia Type 1/therapy , Neoplasm Recurrence, Local/therapy , Parathyroid Neoplasms/therapy , Adult , Aged , Humans , Injections, Subcutaneous , Middle Aged , Retrospective Studies , Treatment Outcome
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL